Able to swallow and retain oral medication.
Must be able to swallow pills
Ability to swallow oral medications
Patients must be able to swallow pills
Able to swallow and retain oral medication (note: for patients unable to swallow tablets, an oral suspension preparation is acceptable)
Patients must be able and willing to swallow and retain oral medication.
Subject is able to swallow and retain oral medication and does not have uncontrolled emesis or gastrointestinal disorders likely to interfere with absorption of the study medication
Patients must be able to swallow pills and must not have malabsorption problems or ongoing nausea and vomiting that would affect oral treatment
Inability to swallow oral medications
Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient is able to swallow, retain, and absorb oral medication
Inability to swallow oral medications
Able to swallow pills whole and retain oral medication
Unable to swallow oral medications
Able to swallow oral medication as an intact dosage form
Subject must be able to swallow solid dosage forms.
Patient must have the ability to swallow and retain oral medication
Subject must be able to swallow and retain oral medication
Ability to swallow oral medications
Patients must be able to swallow and retain oral medication (intact tablet).
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain oral medication and no clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow, retain, and absorb oral medication
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain orally administered medication; does not have any clinically significant gastrointestinal abnormalities, such as malabsorption syndrome or major resection of the stomach or small bowel that may alter absorption of the medication
Subjects must be able to swallow whole capsule.
Participants who are unable to swallow or retain oral medication
Patient must be able to swallow pills whole
Subjects must have the ability to swallow and retain oral medication
Ability to swallow and retain oral medication
Subject is able to swallow pills.
Any condition that may impact the subject's ability to swallow oral medications.
Ability to swallow oral medications without difficulty.
Participants who are unable to swallow or retain oral medication
Ability to swallow the study drug as a whole tablet
The ability to swallow pills and otherwise follow the protocol
Participant must be able to swallow pills
Able to swallow and retain oral medication
Ability to swallow and retain oral medication
Ability to swallow oral medications.
Able to swallow oral medications
Able to swallow and retain oral medication
Participants must be able to swallow and retain oral medication or have an enteral feeding tube in place for study drug administration
Participant is able to swallow a tablet whole
Patient is able to swallow oral medications
Ability to swallow the study drugs
Able to swallow and retain oral medication if needed
Must be able to swallow and retain oral medications
Subject must be able to swallow and retain oral medication
Subject must be able to swallow and retain oral medication
Patients may or may not have neurological symptoms but must be able to swallow and retain oral medication. Be neurologically stable within at least 1 week prior to the first dose of study drug.
The ability to swallow and retain oral medication
Patient must be able to swallow and retain oral medication
Ability to swallow and retain oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Ability to swallow and retain oral medication
Able to swallow and retain oral medication
Inability to swallow oral medications.
Ability to swallow and retain oral medications
Able to swallow oral medication.
Ability to swallow and retain oral medication
Able to swallow and retain oral medication
Able to swallow and retain oral medications
Able to swallow the study drug(s) whole as a tablet
Ability to swallow oral medications
Ability to swallow oral medications.
Ability to be able to swallow and retain orally administered medication.
Ability to swallow the study drug as a whole tablet.
Able to swallow the study drug whole as a tablet
Ability to swallow and retain oral medication
Inability to swallow oral medications
Patients must have the ability to swallow oral dosage forms
Ability to swallow and retain oral medication.
Ability to swallow and retain oral medication
For Combination Therapy cohort only: Able to swallow pills.
Patient must be able to swallow capsule or tablet
Ability to swallow, retain, and absorb oral medication
Patients that unable to swallow oral medications are ineligible
Ability to be able to swallow and retain orally administered medication
Able to swallow the study drug whole as a tablet.
Able to swallow and retain oral medication, and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Able to swallow study drugs whole as a tablet/capsule.
For oral cohorts: subject is able to swallow the oral capsule medication.
Patients must be able to swallow and retain oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to take oral medications (i.e. no feeding tube and able to swallow whole)
Patients must be able to swallow and retain oral medications and be without gastrointestinal illnesses that would preclude absorption of AZD8186
Ability to swallow and retain oral medication
Able to swallow and retain orally administered medication; does not have any clinically significant gastrointestinal abnormalities, such as malabsorption syndrome or major resection of the stomach or small bowel that may alter absorption of the medication
Patients must be able to swallow whole pills
Must be able to swallow pills
Inability to swallow or tolerate oral medication.
Ability to swallow and retain oral medication
Able to swallow study drug
Able to swallow oral medication
Subject must be able to swallow and retain oral medication
Able to swallow and retain oral medication
Participant must be able to swallow pills and retain oral medication and must not have clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Inability to swallow oral medications
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption, such as malabsorption syndrome or major resection of the stomach or bowels
Patient must be able to swallow pills
Patients must have the ability to swallow oral medications
Able to swallow and retain oral medication
Participants must be able to swallow oral pills
Patients must be able and willing to swallow and retain oral medication without a condition that would interfere with enteric absorption
Patient is not able to swallow pills
Must be able to swallow ribociclib and oral aromatase inhibitor, such as letrozole
Ability to swallow oral medications
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow oral medications
Able to swallow oral medication as an intact dosage form
Ability to swallow, retain, and absorb oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Any condition that impairs patient‘s ability to swallow whole pills
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Patient must be able to swallow pills
Ability to swallow and retain oral medication
Patients must be able to swallow pills
Able to swallow oral medication
Ability to swallow and retain oral medication
Able to swallow the study drugs whole
Able to swallow and retain orally-administered medication
Ability to swallow oral medications
Able to swallow the study drugs whole as a tablet
Ability to swallow oral medications
Patient is able to swallow and retain oral medication, unless approval per the manufacturer of other administration routes/methods is provided
Able to swallow study drugs whole as a tablet/capsule
Patients must be able to swallow and retain oral medication
Patient must be able to swallow and retain oral medication
Ability to swallow pills
Subject must be able to swallow and retain oral medication
Ability to swallow oral medications
The subject must be able to swallow ribociclib (LEE011)
Ability to swallow oral medications
Ability to swallow and retain orally-administered medication and does not have any clinically significant gastro-intestinal abnormalities (e.g., malabsorption syndrome or major resection of the stomach or bowel)
Subject must be able to swallow and retain oral medication
Able to swallow pills
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Must be able to swallow pills.
Inability to swallow medication
Patients must be able to swallow and retain oral medication
Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Unable to swallow medication
Able to swallow oral medications
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Must be able to swallow oral medications
Patient has the ability to swallow oral medication and keep a pill diary
Patients must have the ability to swallow oral medication.
Ability to swallow and retain oral tablets
Ability to swallow oral medications
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient is able to swallow and retain oral medication
Able to swallow pills
Patient is able to swallow and retain oral medication
Able to swallow and retain oral medication, and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow oral medications.
Patients must have the ability to swallow pills
Unable to swallow medication or suspected malabsorption
Unable to swallow and retain oral medications
Patient must be able to swallow pills
Any condition that impairs patient‘s ability to swallow whole pills
Willing to take abiraterone acetate on an empty stomach, and should be able to swallow tablets whole, without crushing/chewing tablets; must have the ability to swallow, retain, and absorb oral medication
Must be able to swallow pills
Able to swallow and retain orally-administered medication with no clinically significant gastrointestinal abnormalities that may alter absorption
Can take or swallow medication orally i.e. no chronic or persistent nausea and vomiting
Ability to swallow pills
Willing and able to swallow and retain oral medication. Other protocol defined Inclusion criteria may apply.
Ability to swallow an oral solid-dosage form of medication
Ability to swallow an oral solid-dosage form of medication
Ability to swallow an oral solid-dosage form of medication
Unable to swallow oral medication.
Able to take and retain oral medications
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient is able to swallow and retain oral medication and does not have any clinically significant gastrointestinal abnormalities that may alter drug absorption, such as malabsorption syndrome or major resection of the stomach or bowels.
Ability to swallow and retain oral medication, with no clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient is able to swallow and retain oral medication
Subject must be able to swallow and retain oral medication
Able to swallow and retain oral medication
Able to swallow and retain orally administered medication
Patients must be able to swallow oral medications
Patients must have the ability to swallow and retain oral medication
Patients must be able to swallow oral medication
Inability to swallow medication
Able to swallow and absorb the medication
Able to swallow and retain oral medication
Patients must be able to swallow pills
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow oral medication
Patient must be able to reliably swallow oral medications
Ability to swallow and retain oral medication
Able to swallow or have medication administered through a gastrostomy tube (G-tube) and absorb the medication
Participants must be able and willing to swallow pills and to absorb oral medications
Patient is unable to swallow or keep down oral medication
Ability to swallow oral medications
Able to swallow and retain oral medications and without gastrointestinal (GI) illnesses that would preclude absorption of cediranib or olaparib
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow and retain oral medication
Able to swallow or have medication administered through a gastrostomy (G)-tube and absorb the medication
Willingness and ability to swallow study drugs
Patients must be able to swallow and retain oral medication
Patient is able to swallow and retain oral medication
Subject is able to swallow and retain oral medicines
Patient is able to swallow and retain oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patients must be able to swallow and retain orally-administered medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patients must be able to swallow the drug
Patients must be able to swallow pills
Patient must be able to swallow pills
PHASE II: Patient must be able to swallow pills
Patient must have the ability to swallow and retain orally administered medication
Patients are able to swallow and retain oral medication (i.e., no uncontrolled vomiting, inability to swallow, or diagnosis of chronic malabsorption)
Patient must be able to swallow pills
Any condition that impairs the patient’s ability to swallow whole pills
Participants must be able to swallow oral medications
Patient must be able to swallow pills
Patient must be able to swallow oral medications
Patients must be able to swallow medication by oral route
Patient must be able to swallow and retain oral medication
For subjects to be enrolled in Cohort 4: Able to swallow and retain orally administered tablets
Patients must be able to swallow and retain oral medication
Ability to swallow oral medication
Ability to swallow and retain oral tablets
Inability to swallow oral medication
Patients with a bowel obstruction or any other gastrointestinal condition that might affect absorption of the oral drug should be excluded; this would include patients with inability to swallow and retain orally-administered medication, malabsorption syndrome, or those with a major resection of the stomach or bowels
Patients must be able to swallow and retain orally-administered medication
Inability to swallow or absorb orally-administered medication.
Patients must be able to swallow whole capsule
Ability to swallow study medication
Ability to swallow and retain oral medication
Able to swallow oral formulation of the study agent
Unable to swallow and retain orally administered medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
The patient must be able to swallow oral medication.
Ability to swallow and retain oral medication
Impaired ability to swallow oral medication
Subject cannot reliably swallow pills
Subject must be able to swallow and retain oral medication
Patient is able to swallow and retain oral medication
Subject must be able to swallow and retain oral medication.
Able to swallow oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Are able to swallow oral medications.
All study participants must be able to swallow oral medication
Able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib or olaparib
For orally administered drugs, the patient must be able to swallow and tolerate oral medication and must have no known malabsorption syndrome
Patient must be able to swallow and retain oral medication
Ability to swallow and retain oral medication
Patients who are unable to swallow oral medication are not eligible
Participant must be able to swallow pills
Subject must be able to swallow and retain oral medication
Patient is able to swallow and retain oral medications
Are able to swallow oral medication.
Patients must be able to swallow and retain oral medication
Able to swallow and retain orally administered medication.
Participant has an impaired ability to swallow oral medication.
Participant must be able to swallow pills
Subject must be able to swallow and retain oral medication
Subject has an impaired ability to swallow oral medication.
Patients unable to swallow oral medications
Able to swallow pills
Patients who cannot swallow pills
Ability to swallow oral medication
Patients must have the ability to swallow oral medication.
Patient is able to swallow and retain oral medication
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow and retain oral medication
Patients must be able to reliably take and swallow oral medications
Able to swallow and retain oral medications and begin therapy within 6 to 12 weeks post-surgery
Patient must be able to swallow and retain oral medications
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Able to swallow the study drug as a whole tablet
Patients must be able to swallow oral medication
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient should be able to swallow and retain oral medications
Ability to swallow and retain oral medications.
Subject must be able to swallow and retain oral medication
Able to swallow pills
Subject must be able to swallow and retain oral medication
Patient must be able to swallow capsule or tablet
Any condition that impairs patient‘s ability to swallow whole pills
Subject must be able to swallow and retain oral medication
Patient must be able to swallow and retain oral medication
Able to swallow the study drug whole as a tablet
Ability to swallow oral medications
Must be able to swallow whole pills
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow the study drug whole as a tablet
Patients must have the ability to swallow oral medication.
Are able to swallow and retain oral tablets
Ability to swallow liquids
Able to swallow and retain oral medication
Ability to swallow and retain oral medications.
Has the ability to swallow and retain oral medication and not have any clinically significant gastrointestinal abnormalities that might alter absorption.
Is unable to swallow oral medication
Able to swallow and retain oral medication
Able to swallow the study drug whole as a tablet
Ability to swallow, retain, and absorb oral medication
Ability to swallow and retain oral medications
Ability to swallow and retain oral medications
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Subject must be able to swallow and retain oral medication
Ability to swallow oral medication
Subject must be able to swallow and retain oral medication
Any condition that impairs patient's ability to swallow whole pills
Patient must be able to swallow pills
Patients must be able to swallow and retain oral medication
Patient is not able to swallow oral medication
Able to swallow the study drug whole as a tablet
Ability to swallow and retain oral medication
Subject must be able to swallow and retain oral medication
Patients unable to swallow oral medications.
Able to swallow the study drug whole as a tablet
Able to swallow and absorb the medication
Patient is not able to swallow oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patients must be able to swallow and retain oral medication
Ability to swallow pills and keep medication record
Able to swallow and retain oral medication
The ability to swallow pills
Able to swallow and retain oral medication
Patient is not able to swallow oral medication
Continued ability to swallow and retain orally administered study treatment(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Ability to swallow and retain oral medication
Patients must be able to safely swallow pills.
Ability to swallow and retain oral medication
Able to swallow and retain oral medications
Ability to swallow oral medication
Ability to swallow oral medication
Continued ability to swallow and retain orally administered study treatment(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Inability to swallow or retain oral medication
Able to swallow and retain oral medication;
Inability to swallow oral medications
The ability to swallow and retain oral medication
Patients must be able to swallow pills
Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Continued ability to swallow and retain orally administered study drug(s) and does not have any clinically significant GI abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow oral medications
EXPANSION COHORT ONLY: Able to swallow oral medications
The participant is able to swallow oral medications.
Participant must be able to swallow and retain oral medication
Ability to swallow oral medicines.
Ability to swallow and retain oral medications;
Patient must be able to swallow pills
Unable to swallow medication
Unable to swallow medication; suspected malabsorption
Any condition that impairs patient’s ability to swallow pills will make patient ineligible
Ability to swallow oral medications
Able to swallow medication
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patient must be able to swallow pills
Must be able to swallow and retain oral medication.
Patients must be able to swallow whole pills
Ability to swallow oral medications
Able to swallow the study drugs whole.
Able to swallow pills
Patients are able to swallow and retain oral medication
Ability to swallow medication
Subject must be able to swallow and retain oral medication
Able to swallow and retain oral medication
Subject must be able to swallow and retain oral medication
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Subject must be able to swallow medication
Patient verbalizes the ability to swallow and retain oral medication
Participants must be able to swallow pills to participate in the study
Ability to swallow oral medications.
Ability to swallow oral medication
Able to swallow and retain oral medication.
Must be able to take and retain oral medications.
Patients must be able to swallow and tolerate oral medications
Patients must be able to swallow oral medications
Ability to swallow oral medications
Ability to swallow the study drugs whole.
Able and willing to swallow and retain oral medication.
Able and willing to swallow and retain oral medication.
Participant must be able to swallow and retain orally administered study treatment
History of gastrointestinal disorder or defect. Impaired ability to swallow oral medication. Persistent diarrhea or malabsorption.
Able to swallow and retain oral medication
Inability to swallow oral medications
Patient is able to swallow and retain oral medications
Patients with malabsorption syndrome or other condition that would interfere with intestinal absorption or ability to swallow oral medication
Able to swallow and retain orally administered medication
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow and retain oral medication
Patients unable to swallow and retain oral medications
Ability to swallow and retain oral medication
Ability to swallow study drug whole as a capsule
Able to swallow and retain orally administered study treatment and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Inability to swallow oral medications
Able to swallow and retain enterally (per oral [PO] or nasogastric or gastric tube) administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels.
Subject must be able to swallow and retain oral medication
Patients must be able to swallow and retain oral medication
Patients with malabsorption syndrome or other condition that would interfere with intestinal absorption of pills; patients must be able to swallow pills
Patient must be able to swallow oral medications to be eligible for study enrollment
Able to swallow the study drug whole as a tablet
Any condition that severely impairs patient’s ability to swallow whole pills
Ability to swallow oral medications;
Ability to swallow oral medication
Any condition that impairs patient‘s ability to swallow whole pills
Any condition that impairs patient‘s ability to swallow whole pills
Male or female age 18 years or greater; able to swallow and retain oral medication.
Are able to swallow and retain oral medication.
Any condition that impairs patient‘s ability to swallow whole pills
Able to swallow and retain oral medications;
Ability to swallow and retain oral medication
Patients must be able to swallow pills
Ability to swallow oral medications
Patient is able swallow and absorb oral medications
Ability to swallow and retain oral medication
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Able to swallow pills
Able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow the study drugs
Patient is able to swallow and retain oral medication
Patient is able to swallow and retain oral medication
Able to swallow the study drug (no contraindication to oral agents).
Able to swallow the study drug (no contra indication to oral agents).
Able to swallow the study drug whole as a tablet
Able to swallow thin liquids
Able to swallow oral medications
Patients unable to swallow oral medications
Able to swallow supplements
Inability to swallow study medication
Ability to swallow and retain oral medication or take through a feeding tube
Subject must be able to swallow and retain oral medication
Ability to swallow oral medications
Inability to swallow oral medications
Able to swallow and retain oral medication
Patients must be able to swallow pills
Demonstrate the ability to swallow and retain oral medication
Able to swallow medication
Patient is able to swallow and retain oral medication
Able to swallow oral medications
Patients must have the ability to swallow oral medication
Patients must be able to swallow and retain oral medication
Participant must be able to swallow pills
Participants must be able to swallow the oral doses of erlotinib and PPE
Able to swallow and retain orally-administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Patients must be able to swallow pills
Ability to swallow an oral solid-dosage form of medication
Unable to swallow orally administered medication whole.
Ability to swallow and retain oral medication
Able to swallow pills
Patient is able to swallow a capsule
Ability to swallow study medication
Demonstrate the ability to swallow and retain oral medication
Able to swallow and retain orally administered medication and does not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels
Ability to swallow pills
Able to swallow oral medications
Be able to swallow medication
Ability to swallow and retain oral medication.
Patients ability to swallow oral medication
